Molecules of biological interest that do not fit the wwPDB's criteria. Data includes atomic coordinates, constraints, and other NMR data.
Entry ID | Title |
---|---|
15443 | Structural Study of Ac-Phe-[Orn-Pro-dCha-Trp-Arg], a Potent C5a Receptor Antagonist, by NMR |
16041 | FLNCCPGCCMEP_ReAsH_motif |
20001 | A novel lectin-like peptide from Odorrana grahami |
20002 | Solution structure of RgIA |
20003 | NMR Structure of Leucine-Enkephalin in Water |
20004 | NMR Solution Structure of Leucine-Enkephlain in DMPC+CHAPS (1:4) bicelles in 90% H2O/10% D2O of pH 6.6 at 298K |
20005 | NMR Solution Structure of Leucine-Enkephlain in DMPC+CHAPS (1:4) bicelles in 90% H2O/10% D2O of pH 6.6 at 298K |
20007 | Solution structure of conopressin-T |
20008 | Solution structure of L7P Conopressin-T |
20009 | NMR STRUCTURE OF THE MUTANT OF CHIGNOLIN, CLN025 |
20010 | Superimposed fifteen structures of 17-residue peptide corresponding to the segment within ice nucleation protein of X. campestris pv. campestris |
20011 | NMR STRUCTURE OF THE MUTANT OF CHIGNOLIN, CLN025 |
20012 | Tertiary structure and lipid interactions of short recombinant antimicrobial peptide |
20013 | Tertiary structure and lipid interactions of short recombinant antimicrobial peptide |
20014 | STRUCTURE OF ANTIBACTERIAL PEPTIDE CAPISTRUIN: A 19-RESIDUE LARIAT PROTOKNOT WITH A THREADED 9-MEMBER SIDECHAIN TO-BACKBONE RING |
20015 | NMR structure of a V3 (SF2 isolate) peptide |
20016 | NMR structure of Temporin-SHa in micellar SDS |
20017 | NMR structure of Temporin-SHb in micellar SDS |
20018 | NMR structure of Temporin-SHc in micellar SDS |
20019 | NMR structure of a V3 (MN isolate) peptide |
20020 | NMR structure of a V3 (LAI isolate) peptide |
20022 | 1H Chemical Shift Assignments for metastin analog, s5a |
20023 | Structure, dynamics and selectivity of the sodium channel blocker mu-conotoxin SIIIA |
20024 | NMR solution structure of mu-conotoxin TIIIA |
20025 | NMR solution structure of mu-conotoxin SIIIA |
20026 | Mutagenesis and nuclear magnetic resonance analyses of the fusion peptide of Helicoverpa armigera single nucleocapsid nucleopolyhedrovirus F protein |
20027 | Brome Mosaic Virus protein 1a Helix A bound to SDS micelle |
20028 | Structures of 1-15 peptide fragment of Statherin |
20029 | 13C and 1H atom assignments and structure for Apelin 17 (Human form) at 35C |
20030 | 13C, 1H chemical shifts and structure of apelin 17(human form, major conformation) at 5C |
20031 | 13C, 1H chemical shifts and structure of Apelin 17 (Human form, minor conformation at 5C) |
20032 | Solution structure of Gelatinase Biosynthesis-Activating Pheromone (GBAP), a 11-residue peptide lactone, from the Gram-positive bacterium Enterococcus faecalis |
20033 | Solution structure of dicarba-ImI: an alpha-conotoxin with a non-reducible cystine analogue |
20034 | Solution NMR Structure of 4F Associated With DMPC Disc |
20036 | Cyclic Pseudotetrapeptide L-Phe-L-Trp-L-Lys-L-Thr |
20037 | Cyclic Pseudotetrapeptide D-Phe-L-Trp-L-Lys-L-Thr |
20038 | Cyclic Pseudotetrapeptide L-Phe-D-Trp-L-Lys-L-Thr |
20039 | Cyclic Pseudotetrapeptide L-Phe-L-Trp-D-Lys-L-Thr |
20040 | Cyclic Pseudotetrapeptide D-Phe-D-Trp-D-Lys-L-Thr |
20041 | Cyclic Pseudotetrapeptide L-Phe-D-Trp-D-Lys-L-Thr |
20042 | Cyclic Pseudotetrapeptide L-Phe-L-Trp-D-Lys-D-Thr |
20043 | Cyclic Pseudotetrapeptide L-Phe-D-Trp-L-Lys-D-Thr |
20044 | NMR structure of the Interleukin-8 C-terminal domain in solution with SDS micelles |
20045 | SOLUTION NMR STRUCTURE OF HUMAN IAPP-1-19 |
20046 | SOLUTION NMR STRUCTURE OF RAT IAPP-1-19 |
20047 | INTERACTION OF THE DENGUE VIRUS FUSION PEPTIDE WITH MEMBRANES ASSESSED BY NMR: THE ESSENTIAL ROLE OF THE ENVELOPE PROTEIN TRP101 FOR MEMBRANE FUSION |
20048 | NMR solution structure of an analgesic Mu-contoxin KIIIA |
20049 | NMR solution structure of Mu-KIIIA[C1A,C9A] |
20050 | NMR STRUCTURE OF DPAKKR, A CYCLIC PENTAPEPTIDE MIMIC OF BDNF |
20051 | Biological and structural study of Obestatin and its analogues Structural importance of Obestatin and its biology |
20052 | Solution NMR Structure of Insulin A-chain peptide |
20053 | Solution NMR structure of Insulin A-chain variant peptide |
20054 | Tetramer of KIA7W peptide |
20055 | Tetramer of KIA7H peptide |
20056 | LSEAL penta-peptide Calpain inhibitor |
20057 | NMR structure of designed peptide, YI12WF in the presence of Lipopolysaccharide |
20058 | Solution structure of designed peptide, YI12WW in the presence of Lipopolysaccharide |
20059 | Solution structure of designed peptide, YI12WY in the presence of LPS bilayer |
20060 | Solution structure of designed peptide, YI12FF in the presence of LPS bilayer |
20061 | Solution structure of designed peptide GG8WF in the presence of LPS bilayer |
20062 | 3D NMR models of MBP83-99 peptide in DMSO |
20063 | NMR STRUCTURE OF A MODEL PEPTIDE BOUND TO GROEL |
20064 | Design, Synthesis, Biological Evaluation, and Structural Characterization of Potent Histone Deacetylase Inhibitors Based on Cyclic alpha/beta-tetrapeptide architectures |
20065 | Design, Synthesis, Biological Evaluation, and Structural Characterization of Potent Histone Deacetylase Inhibitors Based on Cyclic alpha/beta-tetrapeptide architectures |
20066 | Design, Synthesis, Biological Evaluation, and Structural Characterization of Potent Histone Deacetylase Inhibitors Based on Cyclic alpha/beta-tetrapeptide architectures |
20067 | Design, Synthesis, Biological Evaluation, and Structural Characterization of Potent Histone Deacetylase Inhibitors Based on Cyclic alpha/beta-tetrapeptide architectures |
20068 | Design, Synthesis, Biological Evaluation, and Structural Characterization of Potent Histone Deacetylase Inhibitors Based on Cyclic alpha/beta-tetrapeptide architectures |
20069 | Design, Synthesis, Biological Evaluation, and Structural Characterization of Potent Histone Deacetylase Inhibitors Based on Cyclic alpha/beta-tetrapeptide architectures |
20070 | Design, Synthesis, Biological Evaluation, and Structural Characterization of Potent Histone Deacetylase Inhibitors Based on Cyclic alpha/beta-tetrapeptide architectures |
20071 | Probing the Bioactive Conformation of an Archetypal Natural Product HDAC Inhibitor Using Conformationally Homogeneous Triazole-Modified Cyclic Tetrapeptides |
20072 | Probing the Bioactive Conformation of an Archetypal Natural Product HDAC Inhibitor Using Conformationally Homogeneous Triazole-Modified Cyclic Tetrapeptides |
20073 | Probing the Bioactive Conformation of an Archetypal Natural Product HDAC Inhibitor Using Conformationally Homogeneous Triazole-Modified Cyclic Tetrapeptides |
20074 | Protein Fibril |
20075 | Solution structure of the N(1-21)MeuTXK-beta in presence of TFE |
20076 | NMR Solution Structure of a TC5b_D9E miniprotein |
20078 | Solution Structure of Antimicrobial Peptide Hedistin |
20079 | NMR solution structure of the loopregion Tyr67 - Leu77 of visual arrestin in complex with lightactivated rhodopsin |
20080 | Structure and interactions in membranes of human and bovine Catestatin by solution and solid-state NMR spectroscopy |
20081 | solution structures of bradykinin - penta-O-galloyl-D-glucopyranose complexe |
20082 | Apelin17 bound to SDS micelles |
20084 | DIRHODIUM PEPTIDE COMPLEX |
20085 | Solution structure of SFT-L1 |
20086 | Helical Agonist of Nociceptin (NOP) Receptor |
20087 | Novel Helix-Constrained Nociceptin Derivatives Are Potent Agonists and Antagonists of ERK Phosphorylation and Thermal Analgesia in Mice |
20088 | Novel Helix-Constrained Nociceptin Derivatives Are Potent Agonists and Antagonists of ERK Phosphorylation and Thermal Analgesia in Mice |
20089 | Novel Helix-Constrained Nociceptin Derivatives Are Potent Agonists and Antagonists of ERK Phosphorylation and Thermal Analgesia in Mice |
20090 | KAAAD, single alpha helix turn |
20091 | RSV_1nal |
20092 | To be advised |
20093 | REV_HIV peptides |
20094 | Effects of Peptoid Residue Substitutions on Structural Flexibility and Bacterial-Cell Selectivity of Piscidin 1 |
20095 | Effects of Peptoid Residue Substitutions on Structural Flexibility and Bacterial-Cell Selectivity of Piscidin 1 |
20098 | Effects of Peptoid Residue Substitutions on Structural Flexibility and Bacterial-Cell Selectivity of Piscidin 1 |
20101 | Lipid-induced Conformation of Substance P |
20102 | C-Terminal helix of the SERCA2b Ca2+ pump (ATP2A2B) |
20103 | Structural studies of antimicrobial peptide XT-7 and its Lysine4 analogue |
20104 | structural studies of antimicrobial peptide XT-7 and its Lysine mutated peptide |
20105 | BI-32169 |
20107 | NMR structure of conotoxin ImI analogue |
20108 | Conformational Flexibility of SecA IRA1 Loop Region |
20109 | CHARACTERIZATION OF THE LIGAND-FREE CONSTITUTIVE ACTIVITY OF THE THROMBOXANE A2 RECEPTOR BY THE INTEGRATED APPROACHES OF NMR SPECTROSCOPY AND A RECOMBINANT RECEPTOR |
20110 | Solution structure of PV1-VPgpU |
20111 | Conformational Flexibility of SecA IRA1 Loop Region |
20112 | CHARACTERIZATION OF THE LIGAND-FREE CONSTITUTIVE ACTIVITY OF THE THROMBOXANE A2 RECEPTOR BY THE INTEGRATED APPROACHES OF NMR SPECTROSCOPY AND A RECOMBINANT RECEPTOR |
20113 | 1H, 13C assignments and NMR structure of temporin-SHf |
20114 | alpha-conotoxin FI |
20115 | Substance P 40 structures in water pH 5.5 298 K NMR DATA & STRUCTURES |
20116 | Substance P in DMPC:CHAPS q=0.25 bicelles |
20117 | Substance P 40 structures in water pH 5.5 298 K NMR DATA & STRUCTURES |
20118 | A 15-residue peptide corresponding to the C-terminal domain of the Gq protein alpha subunit (Gaq-Ct peptide) was synthesized and characterized using NMR spectroscopic studies. |
20119 | Assembling NMR structures for the intracellular loops of the human thromboxane A2 receptor: Implication of the G protein-coupling pocket |
20121 | Tubulysin conformation bound to tubulin |
20122 | Solution structure of CCAP-vil with one disulfide bond from Conus villepinii |
20123 | NS4A(1-22) |
20124 | Structure and lipid interactions of an anti-atherogenic Apolipoprotein J peptide using solution NMR |
20125 | DPC micelle bound VK22 |
20126 | Alpha-conotoxin Vc1.2 |
20127 | Nociceptin Agonist |
20128 | solution structure of conotoxin qc16a |
21000 | Lasso peptide based integrin inhibitor: Microcin J25 variant with RGD substitution of Gly12-Ile13-Gly14 |
21001 | NMR solution of a tridimensional peptidic structure in bilayer lipids: Example with neurotensin in Small Unilamellar Vesicle environment |
21002 | Solution NMR structure of TZ2C-BG |
21006 | alpha-conotoxin ImI cystathionine 2-4 |
21007 | alpha-conotoxin ImI cystathionine 1-3 |
21008 | LPS bound structure of Temporin-1Tl |
21009 | The Binding Mechanism of a Peptidylic Cyclic Serine Protease Inhibitor - upain-1 |
21010 | The Binding Mechanism of a Peptidylic Cyclic Serine Protease Inhibitor - extended upain |
21011 | LPS bound structure of Cysteine deleted TachyplesinI |
21013 | DPC micelle bound RI23 |
21014 | solution structure of conotoxin lt14a |
21015 | solution structure of conotoxin pu14a |
21018 | Compstatin 10 |
21019 | NMR structure, localization and vesicle fusion of Chikungunya Virus Fusion Peptide |
21022 | MDCSGCSRPG cyclic + copper(I) from acidic |
21023 | MDCSGCSRPG head-to-tail cyclic peptide + Cu(I) no metal constraint - high energy ensemble (B) |
21024 | MDCSGCSRPG cyclic peptide bound to Cu(I) from acidic conditions |
21025 | MDCSGCSRPG+Zn from acidic conditions |
21026 | MDCSGCSRPG + Zn from basic conditions |
21027 | MDCSGCSRPG + Zn from basic conditions - tridentate binding |
21028 | MDCSGCSRPG-Zn-water complex from acidic conditions |
21031 | Solution structure of Lewis a [Gal-beta1_3-(Fuc-alpha1_4-)GlcNAc-beta-Me] |
21032 | Solution structure of 1,3-Fucosylated chitobiose |
21033 | Solution structure of Lewis x (Gal-beta1,4-[Fuc-alpha1,3]-GlcNAc-beta) attached to a protein |
21034 | Solution structure of Lewisx (Gal-beta1,4-[Fuc-alpha1,3-]GlcNAc-beta-OMe) at 277 K |
21035 | AIP-III |
21036 | AIP-III_D4A |
21037 | AIP-III_DF5 |
21038 | AIP-III_DL7 |
21039 | AIP-III_F5A cyclic peptide |
21040 | AIP-III_L7A |
21041 | tAIP-III |
21042 | tAIP-III_D2A |
21045 | AIP-I |
21046 | AIP-II |
21047 | AIP-IV |
21053 | Solution structure of fucosylated LacDiNAc (LDNF) |
21054 | Solution structure of the amphibian egg glycan Bv9 from Bombina variegata |
21056 | SFTI-TCTR N12 N14 NMeSer6 |
21057 | SFTI-TCTR N12 N14 |
21099 | Solution structure of U3-MYRTX-Tb1a peptide from Ant venom. |
21102 | Structure of Amphotericin B-Ergosterol Complex |